Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

CD82 regulates STAT5/IL-10 and supports survival of acute myelogenous leukemia cells.

Nishioka C, Ikezoe T, Yang J, Nobumoto A, Kataoka S, Tsuda M, Udaka K, Yokoyama A.

Int J Cancer. 2014 Jan 1;134(1):55-64. doi: 10.1002/ijc.28348. Epub 2013 Jul 27.

PMID:
23797738
[PubMed - indexed for MEDLINE]
2.

CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.

Nishioka C, Ikezoe T, Furihata M, Yang J, Serada S, Naka T, Nobumoto A, Kataoka S, Tsuda M, Udaka K, Yokoyama A.

Int J Cancer. 2013 May 1;132(9):2006-19. doi: 10.1002/ijc.27904. Epub 2012 Oct 30.

PMID:
23055153
[PubMed - indexed for MEDLINE]
3.

IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo.

Yang J, Ikezoe T, Nishioka C, Nobumoto A, Yokoyama A.

Int J Cancer. 2013 Oct 15;133(8):1967-81. doi: 10.1002/ijc.28198. Epub 2013 May 6.

PMID:
23564444
[PubMed - indexed for MEDLINE]
4.

CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express Aurora kinase A.

Yang J, Ikezoe T, Nishioka C, Nobumoto A, Udaka K, Yokoyama A.

Int J Cancer. 2013 Dec 1;133(11):2706-19. doi: 10.1002/ijc.28277. Epub 2013 Jun 10.

PMID:
23686525
[PubMed - indexed for MEDLINE]
5.

FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation.

Yoshimoto G, Miyamoto T, Jabbarzadeh-Tabrizi S, Iino T, Rocnik JL, Kikushige Y, Mori Y, Shima T, Iwasaki H, Takenaka K, Nagafuji K, Mizuno S, Niiro H, Gilliland GD, Akashi K.

Blood. 2009 Dec 3;114(24):5034-43. doi: 10.1182/blood-2008-12-196055. Epub 2009 Oct 6.

PMID:
19808698
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Overexpression of IL-3Rα on CD34+CD38- stem cells defines leukemia-initiating cells in Fanconi anemia AML.

Du W, Li XE, Sipple J, Pang Q.

Blood. 2011 Apr 21;117(16):4243-52. doi: 10.1182/blood-2010-09-309179. Epub 2011 Feb 17.

PMID:
21330473
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Inhibition of signal transducer and activator of transcription 5 by the inhibitor of janus kinases stimulates dormant human leukemia CD34+ /CD38- cells and sensitizes them to antileukemia agents.

Ikezoe T, Yang J, Nishioka C, Kojima S, Takeuchi A, Phillip Koeffler H, Yokoyama A.

Int J Cancer. 2011 May 15;128(10):2317-25. doi: 10.1002/ijc.25806. Epub 2011 Feb 26.

PMID:
21128225
[PubMed - indexed for MEDLINE]
8.

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells.

Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, Meyerrose T, Rossi R, Grimes B, Rizzieri DA, Luger SM, Phillips GL.

Leukemia. 2000 Oct;14(10):1777-84.

PMID:
11021753
[PubMed - indexed for MEDLINE]
9.

Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice.

Ferretti E, Montagna D, Di Carlo E, Cocco C, Ribatti D, Ognio E, Sorrentino C, Lisini D, Bertaina A, Locatelli F, Pistoia V, Airoldi I.

Leukemia. 2012 Feb;26(2):225-35. doi: 10.1038/leu.2011.213. Epub 2011 Aug 16.

PMID:
21844875
[PubMed - indexed for MEDLINE]
10.

MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.

Stroopinsky D, Rosenblatt J, Ito K, Mills H, Yin L, Rajabi H, Vasir B, Kufe T, Luptakova K, Arnason J, Nardella C, Levine JD, Joyce RM, Galinsky I, Reiter Y, Stone RM, Pandolfi PP, Kufe D, Avigan D.

Cancer Res. 2013 Sep 1;73(17):5569-79. doi: 10.1158/0008-5472.CAN-13-0677. Epub 2013 Jul 18.

PMID:
23867470
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.

Cook AM, Li L, Ho Y, Lin A, Li L, Stein A, Forman S, Perrotti D, Jove R, Bhatia R.

Blood. 2014 May 1;123(18):2826-37. doi: 10.1182/blood-2013-05-505735. Epub 2014 Mar 25.

PMID:
24668492
[PubMed - indexed for MEDLINE]
12.

The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cells.

Herrmann H, Kneidinger M, Cerny-Reiterer S, Rülicke T, Willmann M, Gleixner KV, Blatt K, Hörmann G, Peter B, Samorapoompichit P, Pickl W, Bharate GY, Mayerhofer M, Sperr WR, Maeda H, Valent P.

Curr Cancer Drug Targets. 2012 Jan;12(1):51-63.

PMID:
22165967
[PubMed - indexed for MEDLINE]
13.

A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.

Gerber JM, Smith BD, Ngwang B, Zhang H, Vala MS, Morsberger L, Galkin S, Collector MI, Perkins B, Levis MJ, Griffin CA, Sharkis SJ, Borowitz MJ, Karp JE, Jones RJ.

Blood. 2012 Apr 12;119(15):3571-7. doi: 10.1182/blood-2011-06-364182. Epub 2012 Jan 19.

PMID:
22262762
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Preferential eradication of acute myelogenous leukemia stem cells by fenretinide.

Zhang H, Mi JQ, Fang H, Wang Z, Wang C, Wu L, Zhang B, Minden M, Yang WT, Wang HW, Li JM, Xi XD, Chen SJ, Zhang J, Chen Z, Wang KK.

Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5606-11. doi: 10.1073/pnas.1302352110. Epub 2013 Mar 19.

PMID:
23513221
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2.

Tam WF, Hähnel PS, Schüler A, Lee BH, Okabe R, Zhu N, Pante SV, Raffel G, Mercher T, Wernig G, Bockamp E, Sasca D, Kreft A, Robinson GW, Hennighausen L, Gilliland DG, Kindler T.

Cancer Res. 2013 Jan 1;73(1):373-84. doi: 10.1158/0008-5472.CAN-12-0255. Epub 2012 Nov 13.

PMID:
23149921
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Functional expression of Fas (CD95) in acute myeloid leukemia cells in the context of CD34 and CD38 expression: possible correlation with sensitivity to chemotherapy.

Iijima N, Miyamura K, Itou T, Tanimoto M, Sobue R, Saito H.

Blood. 1997 Dec 15;90(12):4901-9.

PMID:
9389707
[PubMed - indexed for MEDLINE]
Free Article
17.

High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.

Witte KE, Ahlers J, Schäfer I, André M, Kerst G, Scheel-Walter HG, Schwarze CP, Pfeiffer M, Lang P, Handgretinger R, Ebinger M.

Pediatr Hematol Oncol. 2011 Mar;28(2):91-9. doi: 10.3109/08880018.2010.528171. Epub 2011 Jan 8.

PMID:
21214408
[PubMed - indexed for MEDLINE]
18.

The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML.

Zhou J, Bi C, Cheong LL, Mahara S, Liu SC, Tay KG, Koh TL, Yu Q, Chng WJ.

Blood. 2011 Sep 8;118(10):2830-9. doi: 10.1182/blood-2010-07-294827. Epub 2011 Jul 6.

PMID:
21734239
[PubMed - indexed for MEDLINE]
Free Article
19.

Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses.

Han L, Wierenga AT, Rozenveld-Geugien M, van de Lande K, Vellenga E, Schuringa JJ.

PLoS One. 2009 Nov 24;4(11):e7989. doi: 10.1371/journal.pone.0007989.

PMID:
19956772
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[Expression of 5 genes in CD7 positive acute myeloid leukemia stem/progenitor cells from bone marrow].

Wu HH, Cao H, Wang YZ, Wang DX, Lin HR, Qin YZ, Chang Y, Hao L, Li LD, Li JL, Ruan GR, Huang XJ, Liu YR.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Apr;17(2):298-303. Chinese.

PMID:
19379555
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk